On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study
- DOI
- 10.3389/fendo.2026.1858266
- Published
- 2026-06-17
- Container
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1858266,
title = {On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study},
author = {Ryo Nakano and Ayumi Ichisawa and Kenya Saruta and Masakazu Kogawa and Akira Fukuda},
year = {2026},
journal = {Frontiers in Endocrinology},
doi = {10.3389/fendo.2026.1858266},
url = {https://doi.org/10.3389/fendo.2026.1858266}
}RIS
TY - JOUR TI - On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study AU - Ryo Nakano AU - Ayumi Ichisawa AU - Kenya Saruta AU - Masakazu Kogawa AU - Akira Fukuda PY - 2026 JO - Frontiers in Endocrinology DO - 10.3389/fendo.2026.1858266 UR - https://doi.org/10.3389/fendo.2026.1858266 ER -
APA
Nakano, R., Ichisawa, A., Saruta, K., Kogawa, M., & Fukuda, A. (2026). On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1858266
Source records
- crossref · retrieved 2026-09-25T20:09:07.282Z